MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from standby
equity purchase...
$2,602,900
Proceeds from sale of
investment in gold
$443,437
Net cash provided by
financing activities
$2,467,900
Net cash provided by
investing activities
$438,042
Canceled cashflow
$135,000
Canceled cashflow
$5,395
Net change in cash
and cash...
$1,116,972
Canceled cashflow
$1,788,970
Principal payments on debt
- related party
$125,000
Payment of debt offering
costs
$10,000
Increase in accrued
expenses and other...
$947,747
Stock issued for
services
$834,600
Warrants
issued/(cancelled) to consultants
-$259,493
Imputed interest -
related party
$79,275
Decrease in operating
lease right-of-use,...
-$55,663
Depreciation expense
$25,113
Fair value of options
issued for services
$22,748
Decrease prepaid
expenses
-$10,799
Purchase of fixed assets
$5,395
Net cash used in
operating activities
-$1,788,970
Canceled cashflow
$2,235,438
Net loss
-$3,623,353
Gain on sale of gold
bullions
$200,433
Net change in
unrealized appreciation...
-$110,198
Decrease in operating
lease liabilities,...
-$56,350
(increase) in inventory
$22,183
Decrease in accounts
payable
-$11,891
Back
Back
Cash Flow
source: myfinsight.com
Kraig Biocraft Laboratories, Inc. (KBLB)
Kraig Biocraft Laboratories, Inc. (KBLB)